Weight-Loss Drugs May Have Surprising Side Effect: Stalling Cancer
- May 22
- 1 min read
New studies suggest drugs like Ozempic, Zepbound might slow tumor progression and improve survival; more research needed to confirm finding
Novo Nordisk is selling its popular weight-loss drug Wegovy directly to U.S. patients at a discount. SHELBY KNOWLES/BLOOMBERG NEWS
The world’s most popular weight-loss and diabetes drugs are linked to a powerful new possible benefit: better outcomes for cancer patients.
Comments